Search Results - "Suto, Takeshi"
-
1
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial
Published in Journal of clinical oncology (01-12-2021)“…Adjuvant chemotherapy after hepatectomy is controversial in liver-only metastatic colorectal cancer (CRC). We conducted a randomized controlled trial to…”
Get full text
Journal Article -
2
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08
Published in British journal of cancer (10-11-2020)“…Background Regorafenib or trifluridine/tipiracil as third-line treatment have limited efficacy in metastatic colorectal cancer (mCRC). Methods This Phase 2…”
Get full text
Journal Article -
3
Clinical Significance of Lymph Node Dissection and Lymph Node Metastasis in Primary Appendiceal Tumor Patients After Curative Resection: a Retrospective Multicenter Cohort Study
Published in Journal of gastrointestinal surgery (2022)“…Purpose Due to its rarity and biological heterogeneity, guidelines for primary appendiceal tumor (PAT) are based on scarce evidence, resulting in no strong…”
Get full text
Journal Article -
4
Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review
Published in Journal of gastroenterology (01-09-2014)“…Background Novel risk factors for lymph node metastasis (LNM) in T1 colorectal cancer (CRC) have been recently proposed, but most have not been implemented…”
Get full text
Journal Article -
5
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial
Published in BMC cancer (28-06-2022)“…Abstract Purpose Although early tumor shrinkage (ETS) is a predictor of improved overall survival (OS), the association between ETS and health-related quality…”
Get full text
Journal Article -
6
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study
Published in International journal of clinical oncology (01-04-2020)“…Background Although regorafenib or trifluridine/tipiracil (FTD/TPI) has been recognized as a later-line standard treatment in patients with metastatic…”
Get full text
Journal Article -
7
Factors affecting R0 resection of colorectal cancer with synchronous peritoneal metastases: a multicenter prospective observational study by the Japanese Society for Cancer of the Colon and Rectum
Published in International journal of clinical oncology (01-02-2020)“…Background In Japan, R0 resection has been recommended for colorectal cancer patients with peritoneal metastases confined to the adjacent peritoneum and those…”
Get full text
Journal Article -
8
Histopathological characteristics of lateral lymph nodes dictate local or distant metastasis and prognosis in low rectal cancer patients
Published in Journal of the Anus, Rectum and Colon (25-07-2018)“…Objectives: The therapeutic value of lateral lymph node dissection in low rectal cancer (RC) patients remains a matter of debate. The present study evaluated…”
Get full text
Journal Article -
9
The Primary Result of Prospective Randomized Multicenter Trial of New Spray-Type Bio-absorbable Adhesion Barrier System (TCD-11091) Against Postoperative Adhesion Formation
Published in Journal of gastrointestinal surgery (01-10-2017)“…Background Postoperative adhesions are the major cause of postoperative complications including intestinal obstruction, infertility, and chronic pelvic pain…”
Get full text
Journal Article -
10
Clinicopathological features of appendiceal goblet cell adenocarcinoma in Japan: a multicenter retrospective study
Published in Surgery today (Tokyo, Japan) (01-02-2023)“…Purpose In the 5th edition of the World Health Organization classification, appendiceal goblet cell adenocarcinoma (GCA) is categorized separately from…”
Get full text
Journal Article -
11
Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study)
Published in Journal of the Anus, Rectum and Colon (25-07-2024)“…Background: The survival benefit of adjuvant chemotherapy after surgical resection of oligometastases from colorectal cancer (CRC) remains unclear. The…”
Get full text
Journal Article -
12
A multicenter cohort study on mapping of lymph node metastasis for splenic flexural colon cancer
Published in Annals of gastroenterological surgery (01-03-2023)“…Aim There have been no reports of searching for metastases to lymph nodes along the accessory middle colic artery (aMCA). The aim of this study was to…”
Get full text
Journal Article -
13
Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies
Published in Journal of the Anus, Rectum and Colon (25-04-2024)“…Background: Spatial and temporal heterogeneities of RAS and other molecular genes should be considered in the treatment of metastatic colorectal cancer (mCRC)…”
Get full text
Journal Article -
14
Surgery to Avoid Stoma Construction in Invasive Prostate Cancer Extensively Infiltrating the Rectum
Published in Case reports in oncology (10-11-2022)“…A 61-year-old man tested positive for occult urinary and fecal occult blood and was diagnosed with invasive prostate cancer extensively infiltrating the…”
Get full text
Journal Article -
15
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
Published in International journal of clinical oncology (01-09-2022)“…Background Primary tumor location is considered a predictor of overall survival (OS) in RAS wild-type (WT) metastatic colorectal cancer (mCRC) treated with…”
Get full text
Journal Article -
16
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment
Published in Frontiers in oncology (15-06-2021)“…Primary tumor location (PTL) is an important prognostic and predictive factor in the first-line treatment of metastatic colorectal cancer (mCRC). Although…”
Get full text
Journal Article -
17
Peritoneal lavage cytology in patients with curative resection for stage II and III colorectal cancer: A multi‐institutional prospective study
Published in Annals of gastroenterological surgery (01-09-2024)“…Aim To clarify the usefulness of intraoperative lavage cytology in patients undergoing curative resection for pStage II‐III colorectal cancer in a prospective…”
Get full text
Journal Article -
18
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)
Published in Frontiers in oncology (08-03-2021)“…The survival benefits of regorafenib (REG) and trifluridine/tipiracil hydrochloride (TFTD) have been demonstrated in chemorefractory patients with metastatic…”
Get full text
Journal Article -
19
Impact of resection for ovarian metastases from colorectal cancer and clinicopathologic analysis: A multicenter retrospective study in Japan
Published in Annals of gastroenterological surgery (01-03-2024)“…Aim The aim of this study was to clarify the significance of resection of ovarian metastases from colorectal cancer and to identify the clinicopathologic…”
Get full text
Journal Article -
20
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer
Published in International journal of clinical oncology (01-06-2017)“…Background Six months of adjuvant chemotherapy is regarded as the standard of care for patients with stage III colon cancer. However, whether longer treatment…”
Get full text
Journal Article